Your browser doesn't support javascript.
loading
Evidence-Informed Milestones for Developmental Surveillance Tools.
Zubler, Jennifer M; Wiggins, Lisa D; Macias, Michelle M; Whitaker, Toni M; Shaw, Judith S; Squires, Jane K; Pajek, Julie A; Wolf, Rebecca B; Slaughter, Karnesha S; Broughton, Amber S; Gerndt, Krysta L; Mlodoch, Bethany J; Lipkin, Paul H.
Afiliação
  • Zubler JM; National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Wiggins LD; Eagle Global Scientific, LLC, San Antonio, Texas.
  • Macias MM; National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Whitaker TM; Division of Developmental-Behavioral Pediatrics, Medical University of South Carolina, Charleston, South Carolina.
  • Shaw JS; Division of Developmental Pediatrics, Department of Pediatrics, The University of Tennessee Health Science Center, Memphis, Tennessee.
  • Squires JK; Vermont Child Health Improvement Program, Department of Pediatrics, Larner College of Medicine, The University of Vermont, Burlington, Vermont.
  • Pajek JA; Center on Human Development (Professor Emerita), University of Oregon, Eugene, Oregon.
  • Wolf RB; MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio.
  • Slaughter KS; National Center on Birth Defects and Developmental Disabilities (retired), Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Broughton AS; National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Gerndt KL; National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Mlodoch BJ; American Academy of Pediatrics, Itasca, Illinois.
  • Lipkin PH; American Academy of Pediatrics, Itasca, Illinois.
Pediatrics ; 149(3)2022 03 01.
Article em En | MEDLINE | ID: mdl-35132439
ABSTRACT
The Centers for Disease Control and Prevention's (CDC) Learn the Signs. Act Early. program, funded the American Academy of Pediatrics (AAP) to convene an expert working group to revise its developmental surveillance checklists. The goals of the group were to identify evidence-informed milestones to include in CDC checklists, clarify when most children can be expected to reach a milestone (to discourage a wait-and-see approach), and support clinical judgment regarding screening between recommended ages. Subject matter experts identified by the AAP established 11 criteria for CDC milestone checklists, including using milestones most children (≥75%) would be expected to achieve by specific health supervision visit ages and those that are easily observed in natural settings. A database of normative data for individual milestones, common screening and evaluation tools, and published clinical opinion was created to inform revisions. Application of the criteria established by the AAP working group and adding milestones for the 15- and 30-month health supervision visits resulted in a 26.4% reduction and 40.9% replacement of previous CDC milestones. One third of the retained milestones were transferred to different ages; 67.7% of those transferred were moved to older ages. Approximately 80% of the final milestones had normative data from ≥1 sources. Social-emotional and cognitive milestones had the least normative data. These criteria and revised checklists can be used to support developmental surveillance, clinical judgment regarding additional developmental screening, and research in developmental surveillance processes. Gaps in developmental data were identified particularly for social-emotional and cognitive milestones.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenvolvimento Infantil / Lista de Checagem Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenvolvimento Infantil / Lista de Checagem Idioma: En Ano de publicação: 2022 Tipo de documento: Article